Advocating for hemp: Industry experts share views at FDA public hearing
Speakers, including manufacturers, retailers, industry experts and even patients, called on the Food and Drug Administration to provide clarity, regulations and consumer education on the fledgling CBD and hemp categories at a public hearing in late May.